This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Nutritional interventions in patients with hair loss (alopecia)

Authoring team

In a systematic review of 30 studies of nutritional interventions, the highest-quality evidence suggests the potential effectiveness for patients with hair loss of:

  • Viviscal,
  • Nourkrin,
  • Nutrafol,
  • Lamdapil,
  • Pantogar,
  • Capsaicin and isoflavone,
  • omega 3 and 6 with antioxidants,
  • apple nutraceutical,
  • total glucosides of paeony and compound glycyrrhizin tablets,
  • zinc,
  • tocotrienol,
  • and pumpkin seed oil

The study authors conclude:

  • findings of this systematic review should be interpreted in the context of each study's design; however, this work suggests a potential role for nutritional supplements in the treatment of hair loss
  • physicians should engage in shared decision-making by covering the potential risks and benefits of these treatments with patients experiencing hair loss

Reference:

  • Drake L, Reyes-Hadsall S, Martinez J, Heinrich C, Huang K, Mostaghimi A. Evaluation of the Safety and Effectiveness of Nutritional Supplements for Treating Hair Loss: A Systematic Review. JAMA Dermatol. Published online November 30, 2022. doi:10.1001/jamadermatol.2022.4867.

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.